References of "Huskin, Jean-Pierre"
     in
Bookmark and Share    
Full Text
Peer Reviewed
See detailQuality of life benefits of knee arthroplasty for osteoarthritis
NEUPREZ, Audrey ULg; François, Garance ULg; KURTH, William ULg et al

in Osteoporosis International (2014), 25(2), 40

Detailed reference viewed: 20 (4 ULg)
Full Text
Peer Reviewed
See detailHealth-related quality of life after total knee or hip replacement for osteoarthritis: a 7-year prospective study
Bruyère, Olivier ULg; Ethgen, Olivier ULg; Neuprez, Audrey ULg et al

in Archives of Orthopaedic & Trauma Surgery (2012)

Objective To assess health-related quality of life (HRQOL) in a prospective study with 7 years of follow-up in 49 consecutive patients who underwent a total joint replacement because of osteoarthritis ... [more ▼]

Objective To assess health-related quality of life (HRQOL) in a prospective study with 7 years of follow-up in 49 consecutive patients who underwent a total joint replacement because of osteoarthritis. Methods Generic HRQOL was assessed with the shortform 36 (SF-36) and specific HRQOL with the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC). Results Out of the 39 subjects who have completed the 7 years of follow-up of this study, 22 (56.4 %) underwent a hip replacement surgery and the other 17 (43.6 %) a knee replacement. Six months after surgery, a significant improvement, compared to preoperative scores, was observed in two of the eight dimensions of the SF-36 (i.e. physical function and pain). The same dimensions, pain and physical function, at the same time, 6 months after surgery, measured by the WOMAC, showed a significant improvement as well, but there was no significant change in the stiffness score. From 6 months to the end of followup, changes in SF-36 scores showed a significant improvement in physical function (p = 0.008), role-physical (p = 0.004) and role-emotional (p = 0.01) while all scores of the WOMAC improved (p\0.001 for pain, p\0.001 for stiffness and p\0.01 for physical function). Conclusion The improvements observed in HRQOL at short term after surgery, are at least maintained over a 7-year follow-up period. [less ▲]

Detailed reference viewed: 43 (19 ULg)
Full Text
Peer Reviewed
See detailRadiological and clinical profil of osteoarthritic patients undergoing of total joint replacement
Neuprez, Audrey ULg; François, Garance ULg; Bruyère, Olivier ULg et al

in Annals of the Rheumatic Diseases (2012, June), 71(Suppl.3), 693

Detailed reference viewed: 38 (15 ULg)
Full Text
Peer Reviewed
See detailRadiological and clinical profil of osteoarthritic patients undergoing of total joint replacement
Neuprez, Audrey ULg; François, Garance ULg; Bruyère, Olivier ULg et al

in Osteoporosis International (2012, March), 23(Suppl. 2), 129-130

Detailed reference viewed: 25 (8 ULg)
Full Text
Peer Reviewed
See detailHealth-related quality of life after total knee or hip replacement: a 7-year prospective study
Bruyère, Olivier ULg; Vanoverberghe, Marie ULg; Neuprez, Audrey ULg et al

in Annals of the Rheumatic Diseases (2010, June), 69(Suppl.3), 469

Detailed reference viewed: 37 (10 ULg)
Full Text
Peer Reviewed
See detailHealth-related quality of life after total knee or hip replacement : a 7-year prospective study
Bruyère, Olivier ULg; Vanoverberghe, Marie ULg; Neuprez, Audrey ULg et al

in Osteoporosis International (2010, May), 21(Suppl.1), 26

Detailed reference viewed: 35 (12 ULg)
Full Text
Peer Reviewed
See detailMulticentre, prospective, open study to evaluate the safety and efficacy of hylan G-F 20 in knee osteoarthritis subjects presenting with pain following arthroscopic meniscectomy.
Huskin, Jean-Pierre ULg; Vandekerckhove, B.; Delince, P. et al

in Knee Surgery, Sports Traumatology, Arthroscopy (2008), 16(8), 747-52

The aim of the study was to evaluate the safety and efficacy of viscosupplementation with hylan G-F 20 in patients with mild to moderate osteoarthritis (OA) presenting with persistent knee pain 4-12 weeks ... [more ▼]

The aim of the study was to evaluate the safety and efficacy of viscosupplementation with hylan G-F 20 in patients with mild to moderate osteoarthritis (OA) presenting with persistent knee pain 4-12 weeks after arthroscopic meniscectomy. A prospective, multi-centre, open study was carried out in patients with pain due to OA of the knee, not resolved by simple analgesics, 4-12 weeks after undergoing arthroscopic meniscectomy. To be eligible, patients had to score > or =50 mm and < or =90 mm on both walking pain and patient global assessment visual analogue scales (VAS; 0-100 mm) at baseline and be radiologically diagnosed pre-operatively with OA grade I or II on the Kellgren-Lawrence scale, with <50% joint space narrowing. Patients received three intra-articular, 2 ml injections of hylan G-F 20 in the target knee with an interval of 1 week between injections, and were followed for 52 weeks. The primary efficacy endpoint was the change from baseline in the walking pain VAS score at 26 weeks. Secondary outcome measures were the walking pain VAS scores at all other time points, the WOMAC Index at all time points, and patient and physician global assessment at all time points. The safety of the treatment was assessed using adverse event (AE) reports. A total of 62 patients (mean age 55.4 years, 52% male) were enrolled. The mean walking pain VAS score decreased by 36.8 mm from baseline at 26 weeks (P < 0.0001), and also showed statistically significant decreases (P < 0.0001) at all other time points. The change in WOMAC total and subscale scores from baseline were statistically significant (P < 0.0001) at all time points, as were the decreases in the physician and patient global assessment VAS scores. There were 18 target knee AEs (mostly pain and/or swelling and/or effusion) in 12 patients (19%) considered to be at least possibly related to treatment. The majority of these (78%) were mild or moderate in intensity. One patient (1.6%) experienced a serious adverse event (synovitis) in the target knee that was considered possibly related to study treatment. Hylan G-F 20 provides effective pain relief and improves stiffness and physical function in patients with mild to moderate OA presenting with persistent osteoarthritic pain 4-12 weeks after arthroscopic meniscectomy. Symptomatic efficacy was maximised at 12 weeks and maintained at 26 and 52 weeks. The type (pain and/or swelling and/or effusion) and the intensity (mostly mild/moderate) of AEs reported in this study are similar to those reported in other trials in different patient populations, but the incidence was higher (19%). The risk/benefit of hylan G-F 20 in this particular population of patients is favourable. [less ▲]

Detailed reference viewed: 40 (7 ULg)
Full Text
Peer Reviewed
See detailRepair of symptomatic cartilage lesions of the knee: the place of autologous chondrocyte implantation.
Vanlauwe, Johan; Almqvist, Frederik; Bellemans, Johan et al

in Acta Orthopaedica Belgica (2007), 73(2), 145-58

An increasing number of patients with cartilage defects of the knee are being treated with autologous chondrocyte implantation (ACI). To date, no clear guidelines exist for the use and indications of this ... [more ▼]

An increasing number of patients with cartilage defects of the knee are being treated with autologous chondrocyte implantation (ACI). To date, no clear guidelines exist for the use and indications of this technique. The BVOT and SOBCOT have established a working group to review the clinical results and the cost-effectiveness of the various treatment modalities and particularly of ACI. This group has formulated recommendations and presents a treatment algorithm based on an in-depth review of recent European and American literature, on peer-reviewed opinions of leading investigators in the field and on a comparative analysis of the clinical results and health-economic aspects of current cartilage repair techniques. [less ▲]

Detailed reference viewed: 83 (2 ULg)
Full Text
See detailIsocinétisme et LCA : quelle position du contre-appui résistif ?
Croisier, Jean-Louis ULg; Maquet, Didier ULg; Huskin, Jean-Pierre ULg et al

in Abstract book de la 5ème Journée Belge d’Isocinétisme (2005, December)

Detailed reference viewed: 101 (4 ULg)
Full Text
Peer Reviewed
See detailMuscle activation after ACL reconstruction: influence of the resistance pad position
Croisier, Jean-Louis ULg; Forthomme, Bénédicte ULg; Baudoin, Hervé et al

in Isokinetics & Exercise Science (2005, March), 13(1), 16-17

Detailed reference viewed: 45 (5 ULg)
See detailExploration isocinétique de l’épaule : mise au point
Forthomme, Bénédicte ULg; Huskin, Jean-Pierre ULg; Willems, S. et al

in Actes des 4èmes Journées Belges d’Isocinétisme (2003, October)

Detailed reference viewed: 46 (5 ULg)
See detailIsocinétisme et conflit sous-acromio-coracoïdien
Forthomme, Bénédicte ULg; Croisier, Jean-Louis ULg; Huskin, Jean-Pierre ULg et al

in Actes de la 3ème Journée Belge d’Isocinétisme (2001, February)

Detailed reference viewed: 24 (2 ULg)
Peer Reviewed
See detailIsokinetic evaluation of knee extensors and flexors in patients with unilateral symptomatic gonarthrosis
Henrotin, Yves ULg; Croisier, Jean-Louis ULg; Dumont, R. et al

in Isokinetics & Exercise Science (2000, March), 8

Detailed reference viewed: 15 (2 ULg)
Full Text
Peer Reviewed
See detailIsokinetic evaluation of knee extensors and flexors in patients with unilateral symptomatic gonarthrosis
Henrotin, Yves ULg; Croisier, Jean-Louis ULg; Dumont, R et al

in Annals of the Rheumatic Diseases (2000), 59(S1), 275

Detailed reference viewed: 8 (2 ULg)